当前位置:首页 - 行情中心 - 济川药业(600566) - 财务分析 - 现金流量表

济川药业

(600566)

  

流通市值:237.75亿  总市值:238.47亿
流通股本:9.19亿   总股本:9.21亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,388,998,967.12,428,914,069.916,639,124,884.525,113,363,265.26
  收到其他与经营活动有关的现金88,178,017.2467,834,825.8117,544,192.93165,223,549.12
  经营活动现金流入小计3,477,176,984.342,496,748,895.716,756,669,077.455,278,586,814.38
  购买商品、接受劳务支付的现金373,767,756.68167,953,607.591,000,015,082.731,042,326,910.81
  支付给职工以及为职工支付的现金456,698,896.59275,877,645.77801,103,602.03635,208,241.16
  支付的各项税费534,257,448.96338,305,925.061,086,765,833.21765,960,005.08
  支付其他与经营活动有关的现金1,257,907,083.91834,272,018.572,670,490,315.582,131,580,287.93
  经营活动现金流出小计2,622,631,186.141,616,409,196.995,558,374,833.554,575,075,444.98
  经营活动产生的现金流量净额854,545,798.2880,339,698.721,198,294,243.9703,511,369.4
二、投资活动产生的现金流量:
  收回投资收到的现金5,285,964,535.591,454,910,021.665,522,548,336.144,301,455,497.24
  取得投资收益收到的现金197,473,296.9825,856,947.77190,636,990.41157,179,525.62
  处置固定资产、无形资产和其他长期资产收回的现金净额565,720600619,084.24129,452.08
  投资活动现金流入小计5,484,003,552.571,480,767,569.435,713,804,410.794,458,764,474.94
  购建固定资产、无形资产和其他长期资产支付的现金220,787,520.26193,682,460.0895,858,707.0471,945,552.18
  投资支付的现金7,048,000,0003,838,000,0006,594,200,0004,949,584,600.05
  投资活动现金流出小计7,268,787,520.264,031,682,460.086,690,058,707.045,021,530,152.23
  投资活动产生的现金流量净额-1,784,783,967.69-2,550,914,890.65-976,254,296.25-562,765,677.29
三、筹资活动产生的现金流量:
  吸收投资收到的现金8,026,3806,595,32020,240,9962,500,000
  取得借款收到的现金1,511,823,690.97826,227,645.061,435,566,424.31761,158,197.31
  筹资活动现金流入小计1,519,850,070.97832,822,965.061,455,807,420.31763,658,197.31
  偿还债务支付的现金640,300,000640,100,000945,342,527.98495,019,590.12
  分配股利、利润或偿付利息支付的现金1,606,706,065.747,311,258.61,928,582,313.441,917,334,555.03
  支付其他与筹资活动有关的现金33,135,278.3425,284,758.3234,151,714.4831,514,184.48
  筹资活动现金流出小计2,280,141,344.08672,696,016.922,908,076,555.92,443,868,329.63
  筹资活动产生的现金流量净额-760,291,273.11160,126,948.14-1,452,269,135.59-1,680,210,132.32
四、汇率变动对现金及现金等价物的影响-25,936.6-10,367.13-9,939.83-
五、现金及现金等价物净增加额-1,690,555,379.2-1,510,458,610.92-1,230,239,127.77-1,539,464,440.21
  加:期初现金及现金等价物余额5,439,123,615.945,439,123,615.946,669,362,743.716,669,362,743.71
  期末现金及现金等价物余额3,748,568,236.743,928,665,005.025,439,123,615.945,129,898,303.5
补充资料:
  净利润782,017,148.28-1,778,264,104.2-
  资产减值准备2,399,671.25-474,140.79-
  固定资产和投资性房地产折旧136,984,047.23-273,734,332.62-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧136,984,047.23-273,734,332.62-
  无形资产摊销23,665,239.18-35,594,277.74-
  长期待摊费用摊销1,823,016.42-1,213,527.11-
  处置固定资产、无形资产和其他长期资产的损失-22,037.21--173,234.04-
  固定资产报废损失170,288.75-445,303.46-
  公允价值变动损失-13,934,805.53--41,312,956.01-
  财务费用13,196,231.93-11,458,926.34-
  投资损失-197,075,105.47--189,887,071.97-
  递延所得税33,175,643.43--2,851,991.79-
  其中:递延所得税资产减少18,353,422.56--7,609,057.5-
    递延所得税负债增加14,822,220.87-4,757,065.71-
  存货的减少-92,338,144.51-258,950,503.83-
  经营性应收项目的减少683,064,185.9--381,958,499.16-
  经营性应付项目的增加-475,659,167.92--555,789,749.81-
  其他-857,419.18-3,957,609.9-
  现金的期末余额3,748,568,236.74-5,439,123,615.94-
  减:现金的期初余额5,439,123,615.94-6,669,362,743.71-
  现金及现金等价物的净增加额-1,690,555,379.2--1,230,239,127.77-
公告日期2026-08-292026-04-242026-04-242025-10-28
审计意见(境内)标准无保留意见
TOP↑